
PercuSense is a medical technology company specializing in continuous multi-analyte biosensor systems that monitor multiple biomarkers such as glucose, lactate, oxygen, ketones, and choline. Their patented sensor technology enables calibration-free, affordable, and compact devices that provide real-time, continuous monitoring tailored to various disease states including diabetes, maternal health complications, and chemical warfare exposure. The company collaborates with research institutions and defense agencies, demonstrating clinical feasibility and advancing sensor applications for metabolic health, maternal-fetal health, and military chemical exposure detection. Their AI-enabled platform offers early detection and intervention capabilities, positioning PercuSense as an innovator in biosensing for healthcare and defense markets.

PercuSense is a medical technology company specializing in continuous multi-analyte biosensor systems that monitor multiple biomarkers such as glucose, lactate, oxygen, ketones, and choline. Their patented sensor technology enables calibration-free, affordable, and compact devices that provide real-time, continuous monitoring tailored to various disease states including diabetes, maternal health complications, and chemical warfare exposure. The company collaborates with research institutions and defense agencies, demonstrating clinical feasibility and advancing sensor applications for metabolic health, maternal-fetal health, and military chemical exposure detection. Their AI-enabled platform offers early detection and intervention capabilities, positioning PercuSense as an innovator in biosensing for healthcare and defense markets.